Current role
Biotechnology · Healthcare
Board Member
2025-05-01–present
Stuart Duty
Board Member
Foghorn Therapeutics Inc. (FHTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Foghorn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get FHTX alertsAbout Stuart Duty
Stuart Duty is recorded as Board Member at Foghorn Therapeutics Inc. (FHTX) since May 1, 2025. Foghorn Therapeutics Inc. reported in an 8-K filed May 1, 2025 that Stuart Duty was appointed Class II director, effective May 1, 2025. Foghorn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Foghorn Therapeutics Inc. includes Adrian Gottschalk (CEO and Board Member), Jeff Sacher (CFO), Kristian F. Humer (CFO and Chief Accounting Officer) and 7 others.
“On April 25, 2025, the Board of Directors (the "Board") of Foghorn Therapeutics Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), appointed Stuart Duty to the Board, effective May 1, 2025.”
Affiliation history
-
Current
2025-05-01–present
Company network
Leadership on record at Foghorn Therapeutics Inc.
- Adrian Gottschalk CEO, Board Member
- Jeff Sacher CFO
- Kristian F. Humer CFO, Chief Accounting Officer
- Ryan D. Maynard CFO
- Ryan Maynard CFO
- Stephen J. DiPalma CFO
- Steven Bellon CTO
- B. Lynne Parshall Board Member
- Ian F. Smith Board Member
- Neil J. Gallagher, M.D., Ph.D. Board Member